LENZ Therapeutics (LENZ) Other Non-Current Assets (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Other Non-Current Assets data on file, last reported at $2.5 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 75.46% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 75.46% YoY) and the FY2025 annual result came in at $2.5 million, up 81.76% from the prior year.
• Other Non-Current Assets fell to $2.5 million in Q1 2026 per LENZ's latest filing, from $2.5 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.7 million in Q4 2023 and bottomed at $1716.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $1.6 million (2025), against an average of $1.4 million.
• The widest annual swing landed in 2023, when Other Non-Current Assets soared 99900.0%; it then plunged 98.76% in 2024.
• Tracing LENZ's Other Non-Current Assets over 5 years: stood at $1.7 million in 2022, then jumped by 58.82% to $2.7 million in 2023, then sank by 48.22% to $1.4 million in 2024, then soared by 81.76% to $2.5 million in 2025, then retreated by 3.46% to $2.5 million in 2026.
• Per Business Quant, the three latest LENZ Other Non-Current Assets figures stand at $2.5 million (Q1 2026), $2.5 million (Q4 2025), and $1.6 million (Q3 2025).

Peer Comparison